BAYCOR

Main information

  • Trade name:
  • BAYCOR 300 FUNGICIDE SPRAY
  • Pharmaceutical form:
  • Emulsifiable
  • Units in package:
  • 1L
  • Class:
  • AgChem
  • Medicine domain:
  • Equipment
  • Medicine type:
  • Agrochemical
  • Manufactured by:
  • BAYER CROPSCIENCE

Documents

Localization

  • Available in:
  • BAYCOR 300 FUNGICIDE SPRAY
    Australia
  • Language:
  • English

Therapeutic information

  • Therapeutic group:
  • BEAN | BEGONIA | BORONIA | CALENDULA OR MARIGOLD | CARNATION | CHRYSANTHEMUM OR TANACETUM | EUCALYPTUS SEEDLING | FUCHSIA | GERA
  • Therapeutic area:
  • Group 3 Fungicide
  • Therapeutic indications:
  • BEAN OR BROAD BEAN RUST- U. VICIAE-FABAE | BLACK SPOT ON ROSE | POWDERY MILDEW | ROSE RUST | RUST | UROMYCES PHASEOLI VAR. TYPICA
  • Product summary:
  • For the control of rust on beans and various ornamentals, black spot on roses and powdery mildew on begonias, eucalyptus seedlings and roses.See Note on Ornamentals (General Instructions) on label.

Other information

Status

  • Source:
  • Australian Pesticides and Veterinary Medicines Authority (APVMA)
  • Authorization status:
  • Registered and available
  • Authorization number:
  • 30381/1103
  • Authorization date:
  • 12-08-2004
  • Last update:
  • 15-06-2017

Patient Information leaflet: composition, indications, side effects, dosage, interactions, adverse reactions, pregnancy, lactation

Baycor

POISON

KEEP OUT OF REACH OF CHILDREN

READ SAFETY DIRECTIONS BEFORE OPENING OR USING

Baycor

®

300

FUNGICIDE SPRAY

Active Constituent:

300 g/L BITERTANOL

Solvent:

539 g/L N-METHYL-2-PYRROLIDONE

GROUP

C

FUNGICIDE

For control of rust on beans and various ornamentals, black spot on roses and powdery mildew on begonias,

eucalyptus seedlings and roses as specified in the DIRECTIONS FOR USE table

GENERAL INSTRUCTIONS

Note on ornamentals: Baycor 300 Fungicide Spray has been used on a wide range of ornamental plant species without

damage. However some species and varieties are particularly sensitive to chemical sprays and as this is often related to

local conditions, it is advisable to treat only a small number of plants first, in order to ascertain their reaction, before

treating the whole crop.

Warning: Some cultivars of Shasta daisy may be damaged, therefore before treating, test Baycor 300 on single plants.

Mixing

Mix the required quantity of Baycor 300 with water in the spray tank and agitate thoroughly. A non-ionic wetting agent

may be added, if required, to ensure effective wetting of foliage. Baycor 300 is a highly effective fungicide with a broad

spectrum of activity. The active constituent penetrates into plant tissue and thus has some measure of depth action.

Besides displaying good protective activity, Baycor 300 has curative action on the disease.

Fungicide Resistance Warning

Baycor 300 Fungicide Spray is a member of the DMI group of fungicides. For fungicide resistance management Baycor

300 Fungicide Spray is a Group C fungicide. Some naturally occurring fungal populations resistant to Baycor 300

Fungicide Spray and other Group C fungicides may exist through normal genetic variability in any fungal population. The

resistant individuals can eventually dominate the fungi population if these fungicides are used repeatedly. These

resistant fungal will not be controlled by Baycor 300 Fungicide Spray and other Group C fungicides, thus resulting in a

reduction in efficacy and possible yield loss. Since the occurrence of resistant fungi is difficult to detect prior to use,

Bayer CropScience Pty Ltd accepts no liability for any losses that result from failure of Baycor 300 Fungicide Spray to

control resistant fungi.

PROTECTION OF WILDLIFE, FISH, CRUSTACEANS AND ENVIRONMENT

Harmful to fish. DO NOT contaminate ponds, waterways and drains with this product or used container.

STORAGE AND DISPOSAL

Store in the closed, original container in a well-ventilated area, as cool as possible. Do not store for prolonged periods in

direct sunlight. Rinse containers before disposal. Add rinsings to spray tank. Do not dispose of undiluted chemicals on

site. Dispose of at a local authority landfill. If no landfill is available, bury the containers below 500 mm in a disposal pit

specifically marked and set up for this purpose clear of waterways, desirable vegetation and tree roots. Empty

containers and product should not be burnt.

SAFETY DIRECTIONS

Harmful if swallowed. Avoid contact with eyes and skin. Will irritate the eyes, nose, throat and skin. Will damage eyes.

Do NOT inhale vapour. When using the product wear cotton overalls buttoned to the neck and wrist, washable hat,

elbow-length butyl rubber gloves, face shield and goggles. If product in eyes, wash it out immediately with water. If

product on skin, immediately wash area with soap and water. After use and before eating, drinking or smoking, wash

hands, arms and face thoroughly with soap and water. After each day's use, wash gloves, face shield, goggles and

contaminated clothing.

FIRST AID

If poisoning occurs, contact a doctor or Poisons Information Centre (telephone 13 11 26). If swallowed, do NOT induce

vomiting. Give a glass of water. If in eyes, hold eyes open, flood with water for at least 15 minutes and see a doctor.

Info

pest

Verified

Baycor

MATERIAL SAFETY DATA SHEET

Additional information is listed in the Material Safety Data Sheet, which can be obtained from

www.bayercropscience.com.au.

EXCLUSION OF LIABILITY

This product must be used strictly as directed, and in accordance with all instructions appearing on the label and in other

reference material. So far as it is lawfully able to do so, Bayer CropScience Pty Ltd accepts no liability or responsibility

for loss or damage arising from failure to follow such directions and instructions.

Baycor

is a registered trademark of Bayer

APVMA Approval No.: 30381/1103

FOR 24 HOUR SPECIALIST ADVICE

IN EMERGENCY ONLY

PHONE 1800 033 111

DIRECTIONS FOR USE

CROP

DISEASE

RATE

CRITICAL COMMENTS

Beans

(Phaseolus vulgaris)

500 mL/ha

Spray when rust infection begins or at budding, whichever

is the earlier. Repeat application

14 days later. A third application may be necessary

where infection occurs early or disease pressure is high.

Ensure thorough coverage of all foliage.

Calendula,

Carnation,

Chrysanthemum,

Pelargonium,

Snapdragon,

Fuchsia,

Boronia

Rust

Use only high volume application equipment. Do NOT

use misting machines.

Curative: For existing infections, spray to

run-off ensuring thorough coverage of all foliage including

the underside of leaves in a series of 3 applications at 5

day intervals.

Preventive: Spray to run-off ensuring thorough coverage

of all foliage including the underside of leaves every 7 to

14 days according to infection pressure.

Rust

(Qld only)

Black spot

170 mL/100 L

Rose

Begonia,

Eucalyptus seedlings

Powdery

mildew

130 mL/100 L

Use only high volume application equipment. Do NOT

use misting machines. Spray to run-off ensuring

thorough coverage of all foliage including the underside of

leaves every 7 to 14 days according to infection pressure

or beginning immediately after onset of the disease.

NOT TO BE USED FOR ANY PURPOSE, OR IN ANY MANNER, CONTRARY TO THIS LABEL UNLESS AUTHORISED

UNDER APPROPRIATE LEGISLATION

WITHHOLDING PERIOD

Beans: DO NOT HARVEST FOR 3 DAYS AFTER APPLICATION

7-12-2018

Magnesium citrate malate as a source of magnesium added for nutritional purposes to food supplements

Magnesium citrate malate as a source of magnesium added for nutritional purposes to food supplements

Published on: Thu, 06 Dec 2018 The present scientific opinion deals with the assessment of the bioavailability of magnesium, from the proposed nutrient source, magnesium citrate malate (MgCM), when added for nutritional purposes to food supplements. MgCM is a mixed salt consisting of magnesium cations and citrate and malate anions, and with a magnesium content of 12–15%. MgCM is proposed to be used in food supplements that are intended to provide up to 300–540 mg/day magnesium. The data provided demonst...

Europe - EFSA - European Food Safety Authority Publications

15-11-2018

Safety evaluation of the food enzyme acetolactate decarboxylase from a genetically modified Bacillus licheniformis (strain NZYM‐JB)

Safety evaluation of the food enzyme acetolactate decarboxylase from a genetically modified Bacillus licheniformis (strain NZYM‐JB)

Published on: Wed, 14 Nov 2018 The food enzyme acetolactate decarboxylase (α‐acetolactate decarboxylase; EC 4.1.1.5) is produced with a genetically modified Bacillus licheniformis strain NZYM‐JB by Novozymes A/S. The genetic modifications do not give rise to safety concerns. The food enzyme is free from viable cells of the production organism and recombinant DNA. This acetolactate decarboxylase is intended to be used in distilled alcohol production and brewing processes. Residual amounts of total organi...

Europe - EFSA - European Food Safety Authority Publications

14-11-2018

“Vita-X Revitalizing Capsules” for men may pose serious health risks

“Vita-X Revitalizing Capsules” for men may pose serious health risks

Health Canada is advising Canadians that two versions of “Vita-X Revitalizing Capsules” by Lanlay Healthmetic Inc., promoted for “long lasting vital energy for men,” may pose serious health risks. One version contains seven capsules and has “NPN 80053009,” a Natural Product Number (NPN) indicating Health Canada authorization, on the label. The second version contains one capsule, has no NPN on the label and is not authorized by Health Canada.

Health Canada

30-10-2018

Sciegen Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Irbesartan Tablets, USP  75 Mg, 150 Mg, and 300 Mg Due to The Detection of Trace Amounts of NDEA (N-Nitrosodiethylamine) Impurity Found in The Active Pharmaceutical Ingredient (API)

Sciegen Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Irbesartan Tablets, USP 75 Mg, 150 Mg, and 300 Mg Due to The Detection of Trace Amounts of NDEA (N-Nitrosodiethylamine) Impurity Found in The Active Pharmaceutical Ingredient (API)

ScieGen Pharmaceuticals, Inc. is voluntarily recalling listed lots, within expiry, of Irbesartan Tablets, USP 75 mg, 150 mg, and 300 mg dosage forms to the consumer level. These products are being recalled due to the presence of an impurity, N-nitrosodiethylamine (NDEA) contained in the API Irbesartan, USP manufactured by Aurobindo Pharma Limited. This impurity, which is a substance that occurs naturally in certain foods, drinking water, air pollution, and industrial processes, has been classified as a...

FDA - U.S. Food and Drug Administration

30-10-2018

Pest categorisation of Aleurocanthus spp.

Pest categorisation of Aleurocanthus spp.

Published on: Mon, 29 Oct 2018 00:00:00 +0100 The Panel on Plant Health performed a pest categorisation of Aleurocanthus spp., a well‐defined insect genus of the whitefly family Aleyrodidae (Arthropoda: Hemiptera). Difficulties within the taxonomy of the genus give doubt about the ability to accurately identify some members to species level. Nevertheless, the genus is thought to currently include about ninety species mainly reported from tropical and subtropical areas. The genus is listed in Council Dir...

Europe - EFSA - European Food Safety Authority Publications

18-10-2018

Stewart’s Shops Issues Allergy Alert on Undeclared Milk in Cranberry Apple Refresher

Stewart’s Shops Issues Allergy Alert on Undeclared Milk in Cranberry Apple Refresher

Saratoga Springs, NY - Stewart’s Shops Corp. is recalling units of Stewart’s Shops brand Cranberry Apple Refresher 16 fluid oz. because the product may contain undeclared milk. People who have an allergy to milk run the risk of serious or life-threatening allergic reaction if they consume this product. Approximately 2,300 units of affected product were distributed in upstate New York and Southern Vermont.

FDA - U.S. Food and Drug Administration

12-9-2018

FDA takes new steps to address epidemic of youth e-cigarette use, including a historic action against more than 1,300 retailers and 5 major manufacturers for their roles perpetuating youth access

FDA takes new steps to address epidemic of youth e-cigarette use, including a historic action against more than 1,300 retailers and 5 major manufacturers for their roles perpetuating youth access

FDA takes new steps to address epidemic of youth e-cigarette use, including a historic action against more than 1,300 retailers and 5 major manufacturers for their roles perpetuating youth access

FDA - U.S. Food and Drug Administration

19-7-2018

Openfoodtox: over 300 substances added to EFSA chemical hazards database

Openfoodtox: over 300 substances added to EFSA chemical hazards database

Openfoodtox: over 300 substances added to EFSA chemical hazards database

Europe - EFSA - European Food Safety Authority Press Releases & News Stories

17-5-2018

JAGUAR 30000 capsules

JAGUAR 30000 capsules

Safety advisory

Therapeutic Goods Administration - Australia

27-4-2018

EpiPen 300 mcg adrenaline auto-injector

EpiPen 300 mcg adrenaline auto-injector

Medicine shortages

Therapeutic Goods Administration - Australia

13-6-2017

Annual report 2016 - Clinical trials of medicines

Annual report 2016 - Clinical trials of medicines

LLast year, the Danish Medicines Agency received 286 clinical trial applications. This is a small decline compared to 2015. However, the number of clinical trial applications has remained stable at around 300 applications per year since 2013.

Danish Medicines Agency

6-4-2017

More batches of EpiPen® are withdrawn

More batches of EpiPen® are withdrawn

MEDA has decided to withdraw four more batches of EpiPen®. The withdrawal concerns two batches of EpiPen® 300 micrograms/dose and two batches of EpiPen® Jr 150 micrograms/dose. The latter is used for acute hypersensitivity reactions in children. The reason for the withdrawal is that there is a risk that the auto-injector does not work.

Danish Medicines Agency

17-3-2017

Withdrawal of a batch of EpiPen® 300 micrograms

Withdrawal of a batch of EpiPen® 300 micrograms

MEDA recalls a batch of the adrenaline product EpiPen® 300 micrograms/dose, which is used for sudden allergic reactions. There is a risk that the auto-injector does not work. The withdrawal concerns product number 578818 with batch number: 5FA665B and expiry date 03/2017.

Danish Medicines Agency

21-2-2017

Takeda Pharma A/S recalls batch of Pamol® in packs of 300 film-coated tablets

Takeda Pharma A/S recalls batch of Pamol® in packs of 300 film-coated tablets

Takeda Pharma A/S recalls a batch of Pamol® in packs of 300 film-coated tablets after the discovery of Ibumetin 600 mg containing ibuprofen in some packs. Both types of medicine are used for the treatment of mild pain, but they work in different ways and may cause different adverse reactions.

Danish Medicines Agency

27-6-2018

Yondelis (Pharma Mar S.A.)

Yondelis (Pharma Mar S.A.)

Yondelis (Active substance: Trabectedin) - PSUSA - Modification - Commission Decision (2018)4096 of Wed, 27 Jun 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/PSUSA/3001/201709

Europe -DG Health and Food Safety

16-5-2018

Busulfan Fresenius Kabi (Fresenius Kabi Deutschland GmbH)

Busulfan Fresenius Kabi (Fresenius Kabi Deutschland GmbH)

Busulfan Fresenius Kabi (Active substance: busulfan) - Centralised - Transfer Marketing Authorisation Holder - Commission Decision (2018)3005 of Wed, 16 May 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/2806/T/8

Europe -DG Health and Food Safety

15-5-2018

Lonquex (UAB Sicor Biotech)

Lonquex (UAB Sicor Biotech)

Lonquex (Active substance: lipegfilgrastim) - Centralised - Renewal - Commission Decision (2018)3009 of Tue, 15 May 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/2556/R/39

Europe -DG Health and Food Safety

15-5-2018

Izba (Novartis Europharm Limited)

Izba (Novartis Europharm Limited)

Izba (Active substance: travoprost) - Centralised - Transfer Marketing Authorisation Holder - Commission Decision (2018)3002 of Tue, 15 May 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/2738/T/10

Europe -DG Health and Food Safety

15-5-2018

KEYTRUDA (Merck Sharp and Dohme B.V.)

KEYTRUDA (Merck Sharp and Dohme B.V.)

KEYTRUDA (Active substance: pembrolizumab) - Centralised - Transfer Marketing Authorisation Holder - Commission Decision (2018)3003 of Tue, 15 May 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/3820/T/45

Europe -DG Health and Food Safety

15-5-2018

LIFMIOR (Pfizer Limited)

LIFMIOR (Pfizer Limited)

LIFMIOR (Active substance: etanercept) - Centralised - Yearly update - Commission Decision (2018)3004 of Tue, 15 May 2018

Europe -DG Health and Food Safety

15-5-2018

Travatan (Novartis Europharm Limited)

Travatan (Novartis Europharm Limited)

Travatan (Active substance: Travoprost) - Centralised - Transfer Marketing Authorisation Holder - Commission Decision (2018)3001 of Tue, 15 May 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/390/T/59

Europe -DG Health and Food Safety

15-5-2018

Imatinib Teva B.V. (Teva B.V.)

Imatinib Teva B.V. (Teva B.V.)

Imatinib Teva B.V. (Active substance: imatinib) - Centralised - Withdrawal - Commission Decision (2018)3008 of Tue, 15 May 2018

Europe -DG Health and Food Safety

15-5-2018

Instanyl (Takeda Pharma A/S)

Instanyl (Takeda Pharma A/S)

Instanyl (Active substance: Fentanyl ) - PSUSA - Modification - Commission Decision (2018)3006 of Tue, 15 May 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/959/PSUSA/1369/201704

Europe -DG Health and Food Safety

15-5-2018

PecFent (Kyowa Kirin Services Ltd)

PecFent (Kyowa Kirin Services Ltd)

PecFent (Active substance: Fentanyl ) - PSUSA - Modification - Commission Decision (2018)3007 of Tue, 15 May 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/1164/PSUSA/1369-201704

Europe -DG Health and Food Safety